Literature DB >> 35895578

Sexual Mixing by HIV Status and Pre-exposure Prophylaxis Use Among Men Who Have Sex With Men: Addressing Information Bias.

Kevin M Maloney1,2, David Benkeser3, Patrick S Sullivan1, Colleen Kelley4, Travis Sanchez1, Samuel M Jenness1.   

Abstract

BACKGROUND: Population-level estimates of sexual network mixing for parameterizing prediction models of pre-exposure prophylaxis (PrEP) effectiveness are needed to inform prevention of HIV transmission among men who have sex with men (MSM). Estimates obtained by egocentric sampling are vulnerable to information bias due to incomplete respondent knowledge.
METHODS: We estimated patterns of serosorting and PrEP sorting among MSM in the United States using data from a 2017-2019 egocentric sexual network study. Respondents served as proxies to report the HIV status and PrEP use of recent sexual partners. We contrasted results from a complete-case analysis (unknown HIV and PrEP excluded) versus a bias analysis with respondent-reported data stochastically reclassified to simulate unobserved self-reported data from sexual partners.
RESULTS: We found strong evidence of preferential partnering across analytical approaches. The bias analysis showed concordance between sexual partners of HIV diagnosis and PrEP use statuses for MSM with diagnosed HIV (39%; 95% simulation interval: 31, 46), MSM who used PrEP (32%; 21, 37), and MSM who did not use PrEP (83%; 79, 87). The fraction of partners with diagnosed HIV was higher among MSM who used PrEP (11%; 9, 14) compared with MSM who did not use PrEP (4%; 3, 5). Comparatively, across all strata of respondents, the complete-case analysis overestimated the fractions of partners with diagnosed HIV or PrEP use.
CONCLUSIONS: We found evidence consistent with HIV and PrEP sorting among MSM, which may decrease the population-level effectiveness of PrEP. Bias analyses can improve mixing estimates for parameterization of transmission models.
Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35895578      PMCID: PMC9561018          DOI: 10.1097/EDE.0000000000001525

Source DB:  PubMed          Journal:  Epidemiology        ISSN: 1044-3983            Impact factor:   4.860


  38 in total

1.  Preexposure chemoprophylaxis for HIV prevention in men who have sex with men.

Authors:  Robert M Grant; Javier R Lama; Peter L Anderson; Vanessa McMahan; Albert Y Liu; Lorena Vargas; Pedro Goicochea; Martín Casapía; Juan Vicente Guanira-Carranza; Maria E Ramirez-Cardich; Orlando Montoya-Herrera; Telmo Fernández; Valdilea G Veloso; Susan P Buchbinder; Suwat Chariyalertsak; Mauro Schechter; Linda-Gail Bekker; Kenneth H Mayer; Esper Georges Kallás; K Rivet Amico; Kathleen Mulligan; Lane R Bushman; Robert J Hance; Carmela Ganoza; Patricia Defechereux; Brian Postle; Furong Wang; J Jeff McConnell; Jia-Hua Zheng; Jeanny Lee; James F Rooney; Howard S Jaffe; Ana I Martinez; David N Burns; David V Glidden
Journal:  N Engl J Med       Date:  2010-11-23       Impact factor: 91.245

2.  HIV Viral Load and Transmissibility of HIV Infection: Undetectable Equals Untransmittable.

Authors:  Robert W Eisinger; Carl W Dieffenbach; Anthony S Fauci
Journal:  JAMA       Date:  2019-02-05       Impact factor: 56.272

3.  Preexposure Prophylaxis for HIV Prevention in a Large Integrated Health Care System: Adherence, Renal Safety, and Discontinuation.

Authors:  Julia L Marcus; Leo B Hurley; Charles Bradley Hare; Dong Phuong Nguyen; Tony Phengrasamy; Michael J Silverberg; Juliet E Stoltey; Jonathan E Volk
Journal:  J Acquir Immune Defic Syndr       Date:  2016-12-15       Impact factor: 3.731

4.  Addressing Gaps in HIV Preexposure Prophylaxis Care to Reduce Racial Disparities in HIV Incidence in the United States.

Authors:  Samuel M Jenness; Kevin M Maloney; Dawn K Smith; Karen W Hoover; Steven M Goodreau; Eli S Rosenberg; Kevin M Weiss; Albert Y Liu; Darcy W Rao; Patrick S Sullivan
Journal:  Am J Epidemiol       Date:  2019-04-01       Impact factor: 4.897

5.  Emtricitabine-tenofovir concentrations and pre-exposure prophylaxis efficacy in men who have sex with men.

Authors:  Peter L Anderson; David V Glidden; Albert Liu; Susan Buchbinder; Javier R Lama; Juan Vicente Guanira; Vanessa McMahan; Lane R Bushman; Martín Casapía; Orlando Montoya-Herrera; Valdilea G Veloso; Kenneth H Mayer; Suwat Chariyalertsak; Mauro Schechter; Linda-Gail Bekker; Esper Georges Kallás; Robert M Grant
Journal:  Sci Transl Med       Date:  2012-09-12       Impact factor: 17.956

6.  Sensitivity analysis for nonignorable missingness and outcome misclassification from proxy reports.

Authors:  Michelle Shardell; Eleanor M Simonsick; Gregory E Hicks; Barbara Resnick; Luigi Ferrucci; Jay Magaziner
Journal:  Epidemiology       Date:  2013-03       Impact factor: 4.822

7.  Partner Disclosure of PrEP Use and Undetectable Viral Load on Geosocial Networking Apps: Frequency of Disclosure and Decisions About Condomless Sex.

Authors:  Michael E Newcomb; Melissa C Mongrella; Benjamin Weis; Samuel J McMillen; Brian Mustanski
Journal:  J Acquir Immune Defic Syndr       Date:  2016-02-01       Impact factor: 3.731

8.  Disclosure and Self-Efficacy Among HIV-Positive Men Who Have Sex with Men: A Comparison Between Older and Younger Adults.

Authors:  Monique J Brown; Julianne M Serovich; Judy A Kimberly; Ogie Umasabor-Bubu
Journal:  AIDS Patient Care STDS       Date:  2015-09-08       Impact factor: 5.078

Review 9.  Serosorting and HIV/STI Infection among HIV-Negative MSM and Transgender People: A Systematic Review and Meta-Analysis to Inform WHO Guidelines.

Authors:  Caitlin E Kennedy; Laura J Bernard; Kathryn E Muessig; Kelika A Konda; Elie A Akl; Ying-Ru Lo; Antonio Gerbase; Kevin R O'Reilly
Journal:  J Sex Transm Dis       Date:  2013-04-14

10.  Population-Level Sexual Mixing According to HIV Status and Preexposure Prophylaxis Use Among Men Who Have Sex With Men in Montreal, Canada: Implications for HIV Prevention.

Authors:  Linwei Wang; Nasheed Moqueet; Gilles Lambert; Daniel Grace; Ricky Rodrigues; Joseph Cox; Nathan J Lachowsky; Syed W Noor; Heather L Armstrong; Darrell H S Tan; Ann N Burchell; Huiting Ma; Herak Apelian; Jesse Knight; Marc Messier-Peet; Jody Jollimore; Stefan Baral; Trevor A Hart; David M Moore; Sharmistha Mishra
Journal:  Am J Epidemiol       Date:  2020-01-31       Impact factor: 4.897

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.